117 related articles for article (PubMed ID: 7173315)
1. Regulation of [3H]imipramine binding sites in rat brain regions: effect of neonatal 5,7-dihydroxytryptamine treatment.
Hrdina PD; Pappas BA; Bialik RJ; Ryan CL
Eur J Pharmacol; 1982 Sep; 83(3-4):343-4. PubMed ID: 7173315
[No Abstract] [Full Text] [Related]
2. Pre- and postsynaptic localization of 3H-imipramine binding sites: action of 5-7 dihydroxytryptamine and triton X-100 on subcellular fractions of rat brain.
Stockert M; De Robertis E
J Recept Res; 1986; 6(3-4):283-95. PubMed ID: 2433436
[TBL] [Abstract][Full Text] [Related]
3. Intrahypothalamic 5,7-dihydroxytryptamine facilitates feminine sexual behavior and decreases [3H]imipramine binding and 5-HT uptake.
Luine VN; Frankfurt M; Rainbow TC; Biegon A; Azmitia E
Brain Res; 1983 Apr; 264(2):344-8. PubMed ID: 6850308
[TBL] [Abstract][Full Text] [Related]
4. 3H-Imipramine binding sites in the rat brain. Selective localization on serotoninergic neurones.
Gross G; Göthert M; Ender HP; Schümann HJ
Naunyn Schmiedebergs Arch Pharmacol; 1981; 317(4):310-4. PubMed ID: 7322215
[No Abstract] [Full Text] [Related]
5. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals.
Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM
Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521
[TBL] [Abstract][Full Text] [Related]
6. Distribution of the radioactivity in the central nervous system of the developing rat following intracisternal or subcutaneous administration of 14C-5,7-dihydroxytryptamine.
Sievers J; Baumgarten HG; Klemm HP; Schlossberger HG; Lolova I
Bibl Anat; 1981; (19):302-7. PubMed ID: 7225075
[No Abstract] [Full Text] [Related]
7. Effects of neonatal administration of 5,7-dihydroxytryptamine on locomotor activity.
Lucot JB; Seiden LS
Psychopharmacology (Berl); 1982; 77(2):114-6. PubMed ID: 6812128
[TBL] [Abstract][Full Text] [Related]
8. The effect of 5,7-dihydroxytryptamine on the serum corticosterone resistance to suppression by dexamethasone.
McIntyre IM; Oxenkrug GF; Stanley M; Gershon S
Brain Res; 1984 Aug; 309(1):156-8. PubMed ID: 6488005
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.
Nelson DL; Herbet A; Bourgoin S; Glowinski J; Hamon M
Mol Pharmacol; 1978 Nov; 14(6):983-95. PubMed ID: 732817
[No Abstract] [Full Text] [Related]
10. Sodium-dependent [3H]imipramine binding in rat hippocampus and its relationship to serotonin uptake.
Hrdina PD
Can J Physiol Pharmacol; 1987 Dec; 65(12):2422-7. PubMed ID: 2452679
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of body weight changes after selective serotonin depletion with 5,7-dihydroxytryptamine.
Baez LA; Browning RA; Cusatis M
Prog Neuropsychopharmacol; 1980; 4(2):123-7. PubMed ID: 7403347
[No Abstract] [Full Text] [Related]
12. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
Fischette CT; Nock B; Renner K
Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of 5,7-dihydroxytryptamine administered at birth on the development of brain monoamines.
Lytle LD; Jacoby JH; Nelson MF; Baumgarten HG
Life Sci; 1974 Sep; 15(6):1203-17. PubMed ID: 4549961
[No Abstract] [Full Text] [Related]
14. Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine.
Saller CF; Stricker EM
Neuropharmacology; 1978 Jul; 17(7):499-506. PubMed ID: 692815
[No Abstract] [Full Text] [Related]
15. Relationship between levels and uptake of serotonin and high affinity [3H]imipramine recognition sites in the rat brain.
Hrdina PD; Pappas BA; Roberts DC; Bialik RJ; Ryan CL
Can J Physiol Pharmacol; 1985 Oct; 63(10):1239-44. PubMed ID: 3000552
[TBL] [Abstract][Full Text] [Related]
16. Effect of substance P on the 5,7-dihydroxytryptamine induced alteration of the postnatal development of central serotonin neurons.
Jonsson G; Hallman H
Med Biol; 1983 Apr; 61(2):105-12. PubMed ID: 6192293
[TBL] [Abstract][Full Text] [Related]
17. Developmental changes in serotonin and 5-hydroxyindoleacetic acid concentrations and opiate receptor binding in rat spinal cord following neonatal 5,7-dihydroxytryptamine treatment.
Kirby ML; Mattio TG
Dev Neurosci; 1982; 5(5-6):394-402. PubMed ID: 6186451
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic localization of [3H]-imipramine binding sites: association with serotonergic neurons.
Dawson TM; Wamsley JK
Brain Res Bull; 1983 Sep; 11(3):325-34. PubMed ID: 6416614
[TBL] [Abstract][Full Text] [Related]
19. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
Mueller RA; Towle A; Breese GR
Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
[TBL] [Abstract][Full Text] [Related]
20. Supersensitivity of 5,7-dihydroxytryptamine-treated rats to the respiratory depressant and antitussive effects of dihydrocodeine.
Kamei J; Ogawa M; Kasuya Y
Eur J Pharmacol; 1988 Aug; 153(2-3):305-8. PubMed ID: 3181291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
